ARTICLE | Company News
BioInvent, Novo Nordisk deal
March 26, 2001 8:00 AM UTC
The companies will develop antibodies for use in drug discovery. BioInvent will use its n-CoDeR phage display library to supply human antibodies for use by NVO as research reagents. NVO will use the a...